
Trust Signals
This page was written by the FormBlends Medical Team, reviewed for calculation accuracy against the Ozempic and Wegovy FDA prescribing information (PI), and cross-referenced with USP compounding guidelines. Every dose table is derived from first-principles math, not copied from an unverified secondary source. Evidence confidence ratings follow GRADE methodology. No affiliate links.
Key Takeaways
- At 5 mg/mL, a 0.25 mg starting dose equals exactly 0.05 mL or 5 units on a U-100 insulin syringe. Most calculation errors come from confusing mL with units.
- The Ozempic 2 mg/1.5 mL pen delivers doses in 0.25 mg increments per click; two clicks equals 0.5 mg, eight clicks equals 2 mg (maximum per pen).
- 100 units on a U-100 syringe equals 1.0 mL. At 5 mg/mL that is 5 mg of semaglutide, a dose far above any approved or typical compounded protocol.
- Compounded semaglutide vials are available at both 5 mg/mL and 10 mg/mL; mixing these concentrations up doubles or halves the intended dose and is the most common serious dosing error reported to compounding pharmacies.
- Reconstituted semaglutide should be stored at 2 to 8 degrees Celsius and discarded after 28 days; peptide degradation accelerates above room temperature independent of microbial contamination.
Direct Answer
Table of Contents
- Semaglutide 5 mg/mL Dosage Chart: Full Unit Conversion Table
- How to Convert Semaglutide Dosage in Units: The Math
- Ozempic 2 mg Click Chart: What Each Click Delivers
- Semaglutide 10 mg/mL Dosage Chart and Comparison
- Semaglutide Mixing Chart: Reconstitution Step by Step
- Standard Dose Escalation Schedule
- Evidence Ledger: What the Data Actually Supports
- What Most Pages Get Wrong About Semaglutide Dosing
- Compounded Vial vs. Approved Pen: Honest Comparison
- Label and COA Literacy: How to Verify What Is in Your Vial
- FAQ
Semaglutide 5 mg/mL Dosage Chart: Full Unit Conversion Table
The table below assumes a vial concentration of exactly 5 mg/mL and a standard U-100 insulin syringe (100 units per mL). All values are derived from the formula: Volume (mL) = Dose (mg) / Concentration (mg/mL), then Units = Volume (mL) x 100.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →| Dose (mg) | Volume (mL) | Units on U-100 Syringe | Clinical Context |
|---|---|---|---|
| 0.25 | 0.05 mL | 5 units | Standard starting dose (Ozempic) |
| 0.5 | 0.10 mL | 10 units | Maintenance dose, T2D |
| 1.0 | 0.20 mL | 20 units | Common maintenance / weight loss |
| 1.5 | 0.30 mL | 30 units | Off-label / compounded escalation |
| 2.0 | 0.40 mL | 40 units | Max Ozempic dose; Wegovy sub-maintenance |
| 2.4 | 0.48 mL | 48 units | Wegovy maximum approved dose |
| 5.0 | 1.00 mL | 100 units | Full 1 mL vial draw; not a therapeutic dose |
How to Convert Semaglutide Dosage in Units: The Math
The term "units" in this context does not refer to International Units (IU) used for insulin activity. It refers to the physical graduation markings on a U-100 syringe, where 100 markings span 1.0 mL. This is a volume measurement dressed as a unit count.
Step-by-step formula:
- Obtain the vial concentration (e.g., 5 mg/mL).
- Divide the prescribed dose in mg by that concentration:
0.5 mg / 5 mg/mL = 0.10 mL - Multiply the volume in mL by 100 to read on a U-100 syringe:
0.10 mL x 100 = 10 units
Reverse calculation (what 100 units of semaglutide is in mg):
100 units on a U-100 syringe = 1.0 mL. At 5 mg/mL: 1.0 mL x 5 mg/mL = 5 mg. At 10 mg/mL: 1.0 mL x 10 mg/mL = 10 mg. Neither of these is a clinical dose. The question arises frequently because patients misread "units" and attempt to draw 100 units as if it were an insulin protocol.
Ozempic 2 mg Click Chart: What Each Click Delivers
The Ozempic 2 mg pen (approved for type 2 diabetes) contains 2 mg of semaglutide in 1.5 mL, yielding a concentration of approximately 1.34 mg/mL within the pen cartridge. The delivery mechanism is mechanical, not user-adjustable by volume. Doses are fixed at 0.25 mg, 0.5 mg, 1 mg, and 2 mg per the FDA prescribing information.
The colloquial "click chart" refers to how many clicks of the dose selector correspond to each dose setting. Each click on the Ozempic 2 mg pen advances the selector by 0.25 mg.
| Number of Clicks | Dose Setting | Volume Injected | Approved Use |
|---|---|---|---|
| 1 click | 0.25 mg | ~0.19 mL | Starting dose (weeks 1-4) |
| 2 clicks | 0.50 mg | ~0.37 mL | Maintenance dose |
| 4 clicks | 1.00 mg | ~0.75 mL | Higher maintenance, T2D |
| 8 clicks | 2.00 mg | ~1.50 mL | Maximum approved dose, T2D |
Semaglutide 10 mg/mL Dosage Chart and Comparison
Some compounded vials are prepared at 10 mg/mL to reduce injection volume. Every dose is drawn at half the volume compared to a 5 mg/mL vial.
| Dose (mg) | Units at 5 mg/mL | Units at 10 mg/mL | Error if Concentrations Swapped |
|---|---|---|---|
| 0.25 | 5 units | 2.5 units | Double dose if 10mg/mL used as 5mg/mL |
| 0.5 | 10 units | 5 units | Double dose |
| 1.0 | 20 units | 10 units | Double dose |
| 2.0 | 40 units | 20 units | Double dose |
Doubling the intended semaglutide dose acutely increases the risk of severe nausea, vomiting, dehydration, and hypoglycemia in patients on concurrent insulin or sulfonylureas. This concentration mismatch is one of the most practically dangerous errors in compounded peptide use.
Semaglutide Mixing Chart: Reconstitution Step by Step
Lyophilized (freeze-dried) semaglutide powder requires reconstitution before injection. The target concentration determines how much bacteriostatic water (BAC water) to add.
| Vial Peptide Content | BAC Water to Add | Final Concentration | Number of Doses at 1 mg |
|---|---|---|---|
| 5 mg | 1.0 mL | 5 mg/mL | 5 doses |
| 5 mg | 0.5 mL | 10 mg/mL | 5 doses (smaller volume each) |
| 10 mg | 2.0 mL | 5 mg/mL | 10 doses |
| 10 mg | 1.0 mL | 10 mg/mL | 10 doses (smaller volume each) |
Reconstitution technique matters: Inject BAC water slowly down the inside wall of the vial, not directly onto the powder cake. Gently swirl for 30 to 60 seconds. Do not vortex or shake vigorously. Agitation creates air bubbles and can promote aggregation of the peptide. The solution should be clear and colorless. Any cloudiness, particulate matter, or discoloration is grounds for discarding the vial.
Standard Dose Escalation Schedule
The FDA-approved escalation for Ozempic (T2D) per the prescribing information is as follows. Wegovy (chronic weight management) uses a distinct, slower escalation to a 2.4 mg maximum weekly dose. These are not interchangeable protocols.
| Weeks | Ozempic Dose (T2D) | Wegovy Dose (Weight Mgmt) | Units at 5 mg/mL |
|---|---|---|---|
| 1-4 | 0.25 mg/week | 0.25 mg/week | 5 units |
| 5-8 | 0.5 mg/week | 0.5 mg/week | 10 units |
| 9-12 | 0.5-1.0 mg/week | 1.0 mg/week | 20 units |
| 13-16 | 1.0 mg/week | 1.7 mg/week | 34 units |
| 17+ | Up to 2.0 mg/week | 2.4 mg/week | 48 units |
Evidence Ledger: What the Data Actually Supports
| Claim | Best Evidence Type | Source / Trial | Effect Direction | Confidence |
|---|---|---|---|---|
| Semaglutide 1 mg/week reduces HbA1c in T2D | Human RCT (Phase 3) | SUSTAIN-6 trial (Marso et al., NEJM 2016) | Positive; significant HbA1c reduction | High |
| Semaglutide 2.4 mg/week reduces body weight in obesity | Human RCT (Phase 3) | STEP 1 trial (Wilding et al., NEJM 2021) | Positive; ~15% mean weight reduction | High |
| Dose escalation reduces GI adverse events | Human RCT / PI data | Ozempic FDA PI; STEP trials | Positive; slower escalation better tolerated | Moderate |
| Compounded semaglutide is bioequivalent to Ozempic | No clinical trial data | None identified | Unknown | Very Low |
| Semaglutide base vs. acetate salt has equivalent absorption | No human comparative data | None identified | Unknown | Very Low |
| 28-day expiry of reconstituted semaglutide | Manufacturer stability data (Ozempic PI) | Novo Nordisk Ozempic PI | Stability limit; beyond 28 days not supported | Moderate (applies to approved product; compounded data limited) |
What Most Pages Get Wrong About Semaglutide Dosing
This is the section competitors skip.
1. The "units" language is borrowed, not native. Semaglutide has no biological unit designation. Calling a draw "20 units" is shorthand for reading a U-100 syringe scale. Telling a patient to inject "20 units" without stating the concentration is meaningless and dangerous. Any guide that gives a unit number without tying it to a specific concentration is incomplete.
2. Salt form changes net peptide mass. Semaglutide as supplied in Ozempic is semaglutide sodium. Many compounded powders are semaglutide acetate or semaglutide base (free acid). These have different molecular weights. A COA reporting 5 mg of semaglutide acetate does not contain the same molar quantity of active peptide as 5 mg of semaglutide free base. Most compounding dosing charts ignore this entirely. The clinical magnitude of this difference is not well characterized, but it is not zero.
3. Pen click charts do not apply to vials. The Ozempic pen is a mechanical device calibrated to deliver a fixed volume per dose setting. Drawing from a vial into a syringe relies entirely on accurate volume measurement. A cloudy sight glass, air bubble, or parallax error introduces real dosing variance. At 0.05 mL (a 0.25 mg dose from a 5 mg/mL vial), an error of one small graduation on a U-100 syringe is 20% of the intended dose.
4. Bacteriostatic water is not sterile water and not water for injection. BAC water contains 0.9% benzyl alcohol as a preservative. This inhibits microbial growth after reconstitution but does not render a vial sterile if it was contaminated during compounding. Sterile water for injection (WFI) lacks the preservative and should only be used in single-use preparations. Using tap water or saline for injection is inappropriate and introduces ionic interactions that can precipitate the peptide.
5. Stability data for compounded semaglutide is extrapolated, not measured. The 28-day use period cited on most compounding guides is borrowed from the Ozempic PI, which applies to the approved pre-filled pen product. Lyophilized compounded semaglutide reconstituted with BAC water in a multi-use vial has not been independently validated for a 28-day shelf life. The practical guidance is conservative: use within 28 days, keep refrigerated, and discard if appearance changes.
Compounded Vial vs. Approved Pen: Honest Comparison
| Factor | Compounded Vial (5 mg/mL) | Ozempic / Wegovy Pen | Winner |
|---|---|---|---|
| Dose precision | User-dependent; syringe reading error possible | Fixed mechanical click; validated dose delivery | Approved pen |
| Regulatory status | Not FDA-approved; quality varies by pharmacy | FDA-approved; NDA on file | Approved pen |
| Clinical evidence | No bioequivalence data for compounded product | Extensive Phase 3 RCT data (SUSTAIN, STEP) | Approved pen |
| Cost | Often significantly lower out-of-pocket | High list price; insurance coverage variable | Compounded vial (cost only) |
| Dose flexibility | Any dose achievable by adjusting draw volume | Fixed dose steps only | Compounded vial |
| Salt form transparency | Variable; requires COA review | Semaglutide sodium; stated on label | Approved pen |
| Sterility assurance | USP 797 pharmacy standards; varies | Validated manufacturing; sterility testing | Approved pen |
The compounded vial loses on every quality and safety metric. It wins only on cost and dose granularity. A patient choosing a compounded product for cost reasons is making a reasonable tradeoff if they understand what they are trading away.
Label and COA Literacy: How to Verify What Is in Your Vial
A Certificate of Analysis (COA) from a compounding supplier should contain the following. If any of these are absent, treat the product as unverified.
| COA Element | What to Look For | Red Flag |
|---|---|---|
| Purity by HPLC | Greater than 98% purity | Below 95%, or purity not stated |
| Identity confirmation | Mass spectrometry (MS) matching semaglutide molecular weight | Only HPLC retention time, no MS |
| Salt form | Stated explicitly: base, acetate, or sodium | Not stated; "semaglutide" only |
| Net peptide mass | Weight in mg with lot number | Concentration claimed without mass or volume data |
| Test date and lot number | Recent; traceable to your vial | Undated, or generic batch reference |
| TFA content | Low or absent (TFA is a synthesis byproduct with potential toxicity) | Not tested; TFA level not reported |
TFA (trifluoroacetic acid) note: Solid-phase peptide synthesis uses TFA for deprotection steps. Residual TFA in the final product is a known compounding concern. Reputable suppliers perform ion-exchange purification to reduce TFA. A COA that does not mention TFA testing should be queried.
Reconstituted concentration verification: You cannot confirm final concentration at home. If the dry weight on the COA is 5 mg and you add 1.0 mL BAC water, you have 5 mg/mL assuming 100% transfer efficiency, which is not guaranteed. A residual powder layer on the vial wall or incomplete dissolution reduces the effective concentration. This is an irreducible uncertainty in compounded vial use.
FAQ
How many units is 0.25 mg of semaglutide at 5 mg/mL concentration?
At 5 mg/mL, 0.25 mg equals 0.05 mL, which is 5 units on a U-100 insulin syringe. Formula: dose (mg) divided by concentration (mg/mL) gives volume in mL, then multiply by 100 to get insulin-syringe units.
What does 100 units of semaglutide equal in mg at 5 mg/mL?
100 units on a U-100 syringe equals 1.0 mL. At 5 mg/mL, that is 5 mg of semaglutide. This is a high dose. Verify concentration with your prescriber before drawing any volume.
How do I mix semaglutide vials for injection?
Reconstitute lyophilized semaglutide with bacteriostatic water. Add diluent slowly down the vial wall, gently swirl (do not shake), and allow to dissolve fully. Label the vial with concentration and date. Refrigerate between 2 to 8 degrees Celsius and use within 28 days once reconstituted.
How many clicks is 0.5 mg on the Ozempic 2 mg pen?
On the Ozempic 2 mg/1.5 mL pen, each click advances the dose by 0.25 mg. Two clicks equals 0.5 mg. The pen delivers a maximum of 2 mg total. Doses available are 0.25, 0.5, 1, and 2 mg per the FDA label.
What is the difference between a 5 mg/mL and a 10 mg/mL semaglutide vial?
A 10 mg/mL vial contains twice the drug per mL. The same syringe volume delivers double the dose. A 20-unit draw at 5 mg/mL is 1 mg; the same 20 units at 10 mg/mL is 2 mg. Confusing concentrations is a common and serious dosing error.
How do I convert semaglutide dose in mg to units on a syringe?
Divide the desired dose in mg by the concentration in mg/mL to get mL. Multiply mL by 100 to read on a U-100 insulin syringe. Example: 1 mg divided by 5 mg/mL equals 0.2 mL equals 20 units.
Does semaglutide need to be refrigerated after mixing?
Yes. Reconstituted semaglutide should be stored at 2 to 8 degrees Celsius and used within 28 days. Peptide bonds in GLP-1 analogs degrade faster at room temperature, and bacteriostatic water only suppresses microbial growth, not chemical degradation. Discard if cloudy or particulate is present.
Is compounded semaglutide the same as Ozempic?
No. Ozempic is an FDA-approved, pre-filled pen product with semaglutide sodium. Most compounded products use semaglutide base or acetate salt. Bioequivalence to the approved product has not been established in clinical trials for compounded versions.
What is the standard semaglutide dose escalation schedule?
The FDA-approved Ozempic escalation starts at 0.25 mg weekly for 4 weeks, then 0.5 mg weekly for at least 4 weeks. The dose may be increased to 1 mg, then 2 mg based on tolerability and glycemic response. Wegovy for weight loss follows a similar but distinct escalation to 2.4 mg weekly.
What happens if I accidentally draw too much semaglutide?
Overdose risk includes severe nausea, vomiting, hypoglycemia (especially if combined with insulin or sulfonylureas), and pancreatitis. Do not inject if you suspect a calculation error. Discard the syringe and re-draw after recalculating. Contact a healthcare provider or Poison Control if an overdose occurs.
How do I read a semaglutide COA to verify concentration?
Look for purity percentage by HPLC (ideally above 98%), peptide content or net weight, and the salt form (base, acetate, or TFA). Concentration in the final vial is calculated from the net peptide mass divided by diluent volume. COAs should include lot number, test date, and identity confirmation by mass spectrometry.
Can I use a regular syringe instead of an insulin syringe for semaglutide?
Standard 1 mL syringes marked in 0.1 mL increments can be used, but they are less precise for small volumes like 0.05 mL (a 0.25 mg dose at 5 mg/mL). U-100 insulin syringes with 0.01 mL graduations provide greater accuracy. At low doses, precision matters.
Sources
- Marso SP, et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6). New England Journal of Medicine. 2016;375(19):1834-1844.
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine. 2021;384(11):989-1002.
- Novo Nordisk. Ozempic (semaglutide) injection: US Prescribing Information. FDA. Revised 2023. Available at: fda.gov
- Novo Nordisk. Wegovy (semaglutide) injection: US Prescribing Information. FDA. Revised 2023. Available at: fda.gov
- US Pharmacopeial Convention. USP 797: Pharmaceutical Compounding -- Sterile Preparations. USP-NF. 2023.
- FDA Drug Shortages Database. Semaglutide injection shortage notice. FDA.gov. 2022-2024.
- FDA. Medications Containing Semaglutide: Compounding Considerations. MedWatch Safety Alert. 2024.
Footer Disclaimers
Evidence standard
How this page was source-checked
FormBlends does not claim an individual clinician byline unless a named reviewer is available. For this page, the editorial team checks medical and regulatory claims against primary sources, clinical trials, public datasets, and regulator guidance.
PubMed evidence trail
Research sources used to frame this page
For Semaglutide 5mg/mL Dosage Chart: Units, Clicks & Mixing Guide | FormBlends, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not a claim that every study applies to every patient.
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Primary STEP 1 trial source for semaglutide weight-management efficacy and adverse-event context.
PubMed
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance
Used for maintenance, discontinuation, and weight-regain discussions after semaglutide response.
PubMed
Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight
Supports head-to-head context when pages compare older and newer GLP-1 options.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Semaglutide 5mg/mL Dosage Chart: Units, Clicks & Mixing Guide is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Original tools and data
Use the FormBlends research stack
These assets are built to be useful beyond a single article: shareable data pages, calculators, provider comparisons, and safety checks that give Google and readers something original to crawl.
Editorial refresh
Practical 2026 note for Semaglutide 5mg/mL Dosage Chart
For this peptide therapy page, the 2026 refresh focuses on semaglutide, tirzepatide, cash-pay pricing, safety signals, peptides, dosage so the article stays close to the question behind "Semaglutide 5mg/mL Dosage Chart".
The useful details are the practical ones: what to verify, what changes risk or cost, and which details separate Semaglutide 5mg/mL Dosage Chart from nearby GLP-1, peptide, hormone, or provider-comparison searches.
Readers can use the added context to bring sharper questions to a licensed provider before making a treatment, cost, or care decision.
Custom 2026 image for Semaglutide 5mg/mL Dosage Chart, peptide therapy, and better treatment decision-making.
Download the Peptide Quick Reference Card
A printable 2-page reference covering popular peptides, dosing ranges, stacking protocols, and storage.
Free download. We'll also send helpful GLP-1 guides to your inbox. Unsubscribe anytime.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.
Written by FormBlends Medical Content Team
Medical content team. This article was researched against primary regulatory, trial, prescribing, and manufacturer sources where available. Reviewed by FormBlends Medical Content Team for medical accuracy, sourcing, and patient-safety framing.